Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
16,117,838
-
Share change
-
+3,721,577
-
Total reported value
-
$1,905,196,132
-
Put/Call ratio
-
72%
-
Price per share
-
$118.23
-
Number of holders
-
119
-
Value change
-
+$443,224,811
-
Number of buys
-
82
-
Number of sells
-
40
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q1 2015
As of 31 Mar 2015,
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,117,838 shares.
The largest 10 holders included
FIRST TRUST ADVISORS LP, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, UBS Group AG, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, RAYMOND JAMES & ASSOCIATES, LPL Financial LLC, ROYAL BANK OF CANADA, and Ameriprise Financial Inc.
This page lists
119
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.